AudioCure, in collaboration with Dr. Wernicke (Technical University of Applied Sciences, Wildau), and Dr. Enzensperger (University of Jena) has successfully tested the newly synthesized chemical entity AC102, a betacarboline, in an in vitro screening model. AC102 has been demonstrated to be highly effective at promoting neurite outgrowth, inducing transformation of cells into the neuronal phenotype and activating transcription of neurotrophins. These characteristics make it a perfect candidate for the treatment of inner ear disorders.
